NCT03447886View on ClinicalTrials.gov

Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

March 9, 2018

Primary Completion Date

August 27, 2018

Study Completion Date

August 27, 2018

Conditions
Breast Cancer
Interventions
OTHER

Phone interview

Collecting clinical and socio-demographic information.

Trial Locations (1)

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT03447886 - Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds | Biotech Hunter | Biotech Hunter